PPARG and Cerebral ischemia: Recently, Xia et al. (2018) demonstrated that pretreatment with pioglitazone significantly alleviated ROS generation in cellular and animal models of cerebral ischemia, which is in line with the PPARγ-mediated neuroprotection evoked by amorfrutin B in our experiments [30].